Product cited in:
Jungnickel, Staratschek-Jox, Bräuninger, Spieker, Wolf, Diehl, Hansmann, Rajewsky, Küppers: "Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma." in: The Journal of experimental medicine, Vol. 191, Issue 2, pp. 395-402, 2000 (PubMed).
Karin, Ben-Neriah: "Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity." in: Annual review of immunology, Vol. 18, Issue 8, pp. 621-63, 2000 (PubMed).
Verma, Stevenson: "IkappaB kinase: beginning, not the end." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 22, pp. 11758-60, 1997 (PubMed).
Baldwin: "The NF-kappa B and I kappa B proteins: new discoveries and insights." in: Annual review of immunology, Vol. 14, Issue 8, pp. 649-83, 1996 (PubMed).
Klement, Rice, Car, Abbondanzo, Powers, Bhatt, Chen, Rosen, Stewart: "IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice." in: Molecular and cellular biology, Vol. 16, Issue 5, pp. 2341-9, 1996 (PubMed).
Beg, Sha, Bronson, Baltimore: "Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice." in: Genes & development, Vol. 9, Issue 22, pp. 2736-46, 1995 (PubMed).